1,279
Views
12
CrossRef citations to date
0
Altmetric
Psychiatry

Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics

, , , , , & show all
Pages 135-143 | Received 09 Aug 2017, Accepted 07 Sep 2017, Published online: 12 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruth Milz, Carmela Benson, Karl Knight, Jose Antunes, Dean Najarian, Paola-Maria Lopez Rengel, Steven Wang, Ute Richarz, Srihari Gopal & John M Kane. (2023) The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric Disease and Treatment 19, pages 531-545.
Read now

Articles from other publishers (11)

Vanessa Sanchez-Gistau, María José Moreno, Susana Gómez-Lus, Antoni Sicras-Mainar & Benedicto Crespo-Facorro. (2023) Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study. Frontiers in Psychiatry 14.
Crossref
Guillaume Fond, Bruno Falissard, Philippe Nuss, Cedric Collin, Stephanie Duret, Marc Rabbani, Isabelle De Chefdebien, Isabelle Tonelli, Pierre Michel Llorca & Laurent Boyer. (2023) How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients. Molecular Psychiatry.
Crossref
Hilary PhelpsDee LinAlex KeenanAditya RajuDanmeng HuangChih-Yuan ChengCarmela Benson. (2023) Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans. Journal of Managed Care & Specialty Pharmacy 29:3, pages 303-313.
Crossref
Rosaria Di Lorenzo, Anita Iorio, Margherita Pinelli, Federica Maria Magarini, Mattia Marchi, Andrea Sacchetti, Chiara Calogero, Gian Galeazzi, Paola Ferri, Sergio Rovesti & Alessandro Minarini. (2022) Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs. Neuropsychiatric Disease and Treatment Volume 18, pages 829-846.
Crossref
Sun Lee & Shaina Schwartz. (2021) Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies. Psychiatry Research 306, pages 114277.
Crossref
Federico Bertolini, Giovanni Ostuzzi, Michela Pievani, Andrea Aguglia, Francesco Bartoli, Paola Bortolaso, Camilla Callegari, Mariarita Caroleo, Giuseppe Carrà, Mariangela Corbo, Armando D’Agostino, Pasquale De Fazio, Fabio Magliocco, Giovanni Martinotti, Edoardo Giuseppe Ostinelli, Marco Piero Piccinelli, Federico Tedeschi & Corrado Barbui. (2021) Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study. CNS Drugs 35:6, pages 655-665.
Crossref
Dee Lin, Philippe Thompson-Leduc, Isabelle Ghelerter, Ha Nguyen, Marie-Hélène Lafeuille, Carmela Benson, Panagiotis Mavros & Patrick Lefebvre. (2021) Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis. CNS Drugs 35:5, pages 469-481.
Crossref
Bruce A. Warden & Paul Barton Duell. (2021) Inclisiran: A Novel Agent for Lowering Apolipoprotein B–containing Lipoproteins. Journal of Cardiovascular Pharmacology 78:2, pages e157-e174.
Crossref
Noraly Stam, Heidi Taipale, Antti Tanskanen, Luka Isphording, Cynthia Okhuijsen‐Pfeifer, Catharina C.M. Schuiling‐Veninga, Jens H.J. Bos, Bert J. Bijker, Jari Tiihonen & Jurjen J. Luykx. (2020) Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across Antipsychotics. Clinical and Translational Science 13:6, pages 1170-1177.
Crossref
Anne Andorn, Jay Graham, John Csernansky, John W. Newcomer, Sunita Shinde, Gilbert Muma, Christian Heidbreder & Maurizio Fava. (2019) Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology 39:5, pages 428-433.
Crossref
Michael Musker, Martin David Lewis, Geoffrey Schrader, Vivian Isaac, Jörg Strobel & Niranjan Bidargaddi. (2021) Defining Medication Discontinuation From Prescription Claims Records to Initiate Clinical Intervention in Schizophrenia & Bipolar Disorder: A Systematic Review. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.